Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07486921 · ClinicalTrials.gov registry record · Phase 2
Etrasimod as Prevention of Pouchitis
A Phase 2 study, sponsored by Maia Kayal.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT07486921 is a Phase 2 study that is actively recruiting participants, run by Maia Kayal. The registered enrollment target is 40 participants.
The verdict
NCT07486921, a Phase 2 study, is actively recruiting participants, sponsored by Maia Kayal.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The researchers propose conducting a multi-center, randomized, placebo-controlled study to investigate the potential role of etrasimod for the primary and secondary prevention of pouchitis among high-risk patients submitted to total proctocolectomy (TPC) with ileal-pouch anal anastomosis (IPAA) for medically refractory disease. The trial will be conducted in compliance with this protocol, Good Clinical Practice guidelines, and Institutional Review Board requirements.
Interventions
- DRUG Placebo
- DRUG etrasimod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06-12 |
| Est. Completion | 2030-02-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07486921
The ClinicalTrials.gov registry entry for NCT07486921 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maia Kayal, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07486921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07486921 about?
NCT07486921 is a clinical study titled "Etrasimod as Prevention of Pouchitis". The researchers propose conducting a multi-center, randomized, placebo-controlled study to investigate the potential role of etrasimod for the primary and secondary prevention of pouchitis among high-risk patients submitted to total proctocolectomy (TPC) with ileal-pouch anal anastomosis (IPAA) for ...
What is the current status of trial NCT07486921?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2026-06-12. Estimated completion is 2030-02-06.
What interventions are being tested in trial NCT07486921?
The interventions under investigation include: Placebo (DRUG), etrasimod (DRUG).
Who is sponsoring clinical trial NCT07486921?
This trial is sponsored by Maia Kayal, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.